Antinociception in rat by sarpogrelate, a selective 5-HT 2A receptor antagonist, is peripheral

Author： Obata H.   Saito S.   Ishizaki K.   Goto F.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.404, Iss.1, 2000-09, pp. : 95-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The selective 5-HT 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

By Schmidt C.J.   Fadayel G.M.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 273-279

Elsevier

Access to resources Recommend Favorite

Binding affinity of sarpogrelate to 5-HT2A receptor ligand recognition sites in rat renal cortical and mesangial cells in culture

By Nishio H.   Yoshikawa S.   Morimoto Y.   Chen Z.   Nakata Y.  

General Pharmacology, Vol. 33, Iss. 1, 1999-07 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

EMD 281014, a new selective serotonin 5-HT 2A receptor antagonist

By Bartoszyk G.D.   van Amsterdam C.   Bottcher H.   Seyfried C.A.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 229-230

Elsevier

Access to resources Recommend Favorite

M100907, a selective 5-HT 2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

By Habara T.   Hamamura T.   Miki M.   Ohashi K.   Kuroda S.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 189-194

Elsevier

Access to resources Recommend Favorite

Effects of the 5-HT Receptor Antagonist Sarpogrelate in Diabetic Patients with Complications : A Pilot Study

By Hotta N.  

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 199-207

Adis International

Access to resources Recommend Favorite